Myomo (MYO) Cash from Investing Activities (2017 - 2025)
Myomo (MYO) reported Cash from Investing Activities of $189698.0 for Q3 2025, down 93.29% on a YoY basis from $2.8 million in Q3 2024, and up 125.05% quarter-over-quarter from -$757348.0 in Q2 2025.
Myomo (MYO) Cash from Investing Activities (2017 - 2025) Analysis & Trends
Myomo has reported Cash from Investing Activities for 9 years, with the latest figure at $189698.0 in Q3 2025.
- For the quarter ending Q3 2025, Cash from Investing Activities fell 93.29% year-over-year to $189698.0; the trailing twelve-month figure through Sep 2025 stood at -$3.8 million (down 197.68% YoY), and the FY2024 full-year result was $259981.0, up 112.81% from the prior year.
- Cash from Investing Activities for Q3 2025 stood at $189698.0, up from -$757348.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $2.8 million in Q3 2024, with the low at -$3.5 million in Q1 2024.
- Historically, Cash from Investing Activities has averaged -$256346.7 across 5 years, with a median of -$52793.0 in 2022.
- The largest YoY upside for Cash from Investing Activities was 67882.92% in 2023 against a maximum downside of 22831.05% in 2023.
- Myomo's Cash from Investing Activities stood at -$23935.0 in 2021, then jumped by 85.86% to -$3385.0 in 2022, then jumped by 67882.92% to $2.3 million in 2023, then sank by 158.98% to -$1.4 million in 2024, then surged by 114.02% to $189698.0 in 2025.
- The last three Cash from Investing Activities figures came in at $189698.0 (Q3 2025), -$757348.0 (Q2 2025), and -$1.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 189,698.00 |
| Sep 30, 2025 | 189,698.00 |
| Jun 30, 2025 | -757,348.00 |
| Jun 30, 2025 | -757,348.00 |
| Mar 31, 2025 | -1.90 Mn |
| Mar 31, 2025 | -1.90 Mn |
| Dec 31, 2024 | -1.35 Mn |
| Dec 31, 2024 | -1.35 Mn |
| Sep 30, 2024 | 2.83 Mn |
| Sep 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | -3.54 Mn |
| Mar 31, 2024 | -3.54 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | -1.32 Mn |
| Sep 30, 2023 | -1.32 Mn |
| Jun 30, 2023 | -2.96 Mn |
| Jun 30, 2023 | -2.96 Mn |